Status
Conditions
About
Multicenter Human Derivatives Prospective Cohort Study: Clinical information will be collected from patients with ankylosing spondylitis and their families who have provided research consent. And clinical samples including blood, saliva, feces, and mucosal biopsy tissue (from patients scheduled for sigmoid colonoscopy or routine colonoscopy examinations) will be collected. Multi-omics data production and laboratory analysis will be conducted using the collected samples, followed by integrated bioinformatic analysis using the produced data."
Full description
Enrollment of ankylosing spondylitis patients and family controls who meet the exclusion criteria 2) Collection of standard clinical information items 3) Collect biological samples according to standardized protocols 4) Produce microbiome and multi-omics data from biosamples 5) Conduct clinical research using clinical information items and microbiome and multi-omics data
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:
Family members of patients with ankylosing spondylitis
Exclusion Criteria for Ankylosing Spondylitis Patients:
Exclusion Criteria for Family Members of Ankylosing Spondylitis Patients:
Within a pre-planned period from the date of microbiome collection:
600 participants in 2 patient groups
Loading...
Central trial contact
Tae-Hwan Kim, MD,PhD; Ji-Hui Shin, MS
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal